AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,087 | +27.0% | 8,848 | +1.9% | 0.00% | – |
| Q2 2023 | $7,945 | +63.3% | 8,683 | 0.0% | 0.00% | – |
| Q1 2023 | $4,866 | -11.5% | 8,683 | -8.9% | 0.00% | – |
| Q4 2022 | $5,498 | -99.9% | 9,529 | -61.6% | 0.00% | – |
| Q3 2022 | $7,846,000 | -75.5% | 24,815 | -72.6% | 0.00% | – |
| Q2 2022 | $31,970,000 | +10.0% | 90,540 | +123.7% | 0.00% | – |
| Q1 2022 | $29,056,000 | -81.9% | 40,474 | -42.9% | 0.00% | – |
| Q4 2021 | $160,286,000 | -28.7% | 70,923 | -9.1% | 0.00% | – |
| Q3 2021 | $224,724,000 | -6.0% | 78,029 | +23.7% | 0.00% | – |
| Q2 2021 | $239,028,000 | -5.3% | 63,068 | -15.4% | 0.00% | – |
| Q1 2021 | $252,413,000 | +337.0% | 74,568 | +261.5% | 0.00% | – |
| Q4 2020 | $57,761,000 | -32.3% | 20,629 | -39.3% | 0.00% | – |
| Q3 2020 | $85,327,000 | -44.6% | 33,995 | +199.9% | 0.00% | – |
| Q2 2020 | $153,916,000 | -56.7% | 11,334 | -75.8% | 0.00% | -100.0% |
| Q1 2020 | $355,070,000 | +302.7% | 46,843 | +235.7% | 0.00% | – |
| Q4 2019 | $88,177,000 | +19.8% | 13,952 | -25.7% | 0.00% | – |
| Q3 2019 | $73,594,000 | +47.1% | 18,774 | +81.6% | 0.00% | – |
| Q2 2019 | $50,046,000 | -67.3% | 10,340 | -44.6% | 0.00% | – |
| Q1 2019 | $152,940,000 | +478.8% | 18,674 | +290.8% | 0.00% | – |
| Q4 2018 | $26,422,000 | +65.1% | 4,778 | +163.7% | 0.00% | – |
| Q3 2018 | $16,000,000 | -31.9% | 1,812 | -23.0% | 0.00% | – |
| Q2 2018 | $23,483,000 | -74.0% | 2,353 | -75.2% | 0.00% | – |
| Q1 2018 | $90,373,000 | -30.9% | 9,483 | +7.9% | 0.00% | – |
| Q4 2017 | $130,737,000 | +53.5% | 8,792 | +103.1% | 0.00% | – |
| Q3 2017 | $85,151,000 | +29.3% | 4,329 | -5.6% | 0.00% | – |
| Q2 2017 | $65,872,000 | +12031.1% | 4,584 | +7669.5% | 0.00% | – |
| Q1 2017 | $543,000 | -91.3% | 59 | -90.2% | 0.00% | – |
| Q4 2016 | $6,267,000 | -72.5% | 602 | -76.1% | 0.00% | – |
| Q3 2016 | $22,788,000 | +127.7% | 2,518 | +88.2% | 0.00% | – |
| Q2 2016 | $10,008,000 | -84.7% | 1,338 | -73.5% | 0.00% | – |
| Q4 2015 | $65,220,000 | +33.3% | 5,048 | -0.3% | 0.00% | – |
| Q3 2015 | $48,918,000 | +134.4% | 5,064 | +149.7% | 0.00% | – |
| Q2 2015 | $20,868,000 | +926.5% | 2,028 | +1008.2% | 0.00% | – |
| Q1 2015 | $2,033,000 | -84.3% | 183 | -68.8% | 0.00% | – |
| Q3 2014 | $12,968,000 | – | 586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |